{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:44:43Z","timestamp":1793169883162,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T016515\/1"],"award-info":[{"award-number":["MR\/T016515\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.clim.2023.109287","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T10:57:26Z","timestamp":1678532246000},"page":"109287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["The NLRP3 inflammasome as a target for sensorineural hearing loss"],"prefix":"10.1016","volume":"249","author":[{"given":"Grace E.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar N.","family":"Pathmanaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109287_bb0005","series-title":"Global Health Estimates 2016: Disease burden by Cause, Age, Sex, by Country and by Region, 2000\u20132016","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.clim.2023.109287_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021502","article-title":"Randomised controlled feasibility trial of the Active Communication Education programme plus hearing aid provision versus hearing aid provision alone (ACE to HEAR): a study protocol","volume":"8","author":"Thyer","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.clim.2023.109287_bb0015","series-title":"UK Health Research Analysis 2014","year":"2015"},{"key":"10.1016\/j.clim.2023.109287_bb0020","article-title":"Hearing aids for mild to moderate hearing loss in adults","volume":"9","author":"Ferguson","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.clim.2023.109287_bb0025","author":"World Health Organization"},{"key":"10.1016\/j.clim.2023.109287_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.846804","article-title":"Age-related hearing loss is accompanied by chronic inflammation in the cochlea and the cochlear nucleus","volume":"14","author":"Seicol","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.clim.2023.109287_bb0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/14992027.2014.891057","article-title":"Inflammation is associated with a worsening of presbycusis: evidence from the MRC national study of hearing","volume":"53","author":"Verschuur","year":"2014","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.clim.2023.109287_bb0040","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1121\/1.5132545","article-title":"Inflammation associated with noise-induced hearing loss","volume":"146","author":"Frye","year":"2019","journal-title":"J. Acoust. Soc. Am."},{"key":"10.1016\/j.clim.2023.109287_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00418-016-1436-5","article-title":"Characterisation of cochlear inflammation in mice following acute and chronic noise exposure","volume":"146","author":"Tan","year":"2016","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.clim.2023.109287_bb0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13014-020-01662-9","article-title":"A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response","volume":"15","author":"Zhang","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.clim.2023.109287_bb0055","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MAO.0000000000003014","article-title":"Inflammation at the tissue-electrode Interface in a case of rapid deterioration in hearing performance leading to explant after cochlear implantation","volume":"42","author":"Hough","year":"2021","journal-title":"Otol Neurotol."},{"key":"10.1016\/j.clim.2023.109287_bb0060","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202004003","article-title":"The cell biology of inflammation: from common traits to remarkable immunological adaptations","volume":"219","author":"Weavers","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clim.2023.109287_bb0065","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2023.109287_bb0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2023.109287_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/glia.24095","article-title":"Macrophages in the cochlea; an immunological link between risk factors and progressive hearing loss","volume":"70","author":"Hough","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.clim.2023.109287_bb0080","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202006194","article-title":"The NLRP3-inflammasome as a sensor of organelle dysfunction","volume":"219","author":"Seoane","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clim.2023.109287_bb0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","article-title":"Channelling inflammation: gasdermins in physiology and disease","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2023.109287_bb0090","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.3390\/molecules25235533","article-title":"Inhibiting the NLRP3 Inflammasome","volume":"25","author":"El-Sharkawy","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.clim.2023.109287_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2023.109287_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and management of the Cryopyrin-Associated Periodic Syndromes (CAPS): what do we know today?","volume":"10","author":"Welzel","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.clim.2023.109287_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0194599811402296","article-title":"Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations","volume":"145","author":"Ahmadi","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.clim.2023.109287_bb0110","doi-asserted-by":"crossref","first-page":"E7766","DOI":"10.1073\/pnas.1702946114","article-title":"NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy","volume":"114","author":"Nakanishi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109287_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11940-018-0526-1","article-title":"Cryopyrin-associated periodic fever syndrome and the nervous system","volume":"20","author":"Keddie","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.clim.2023.109287_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.865763","article-title":"Auditory and vestibular characteristics of NLRP3 Inflammasome related autoinflammatory disorders: monogenic hearing loss can be improved by anti-interleukin-1 therapy","volume":"13","author":"Nakanishi","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2023.109287_bb0125","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/rheumatology\/keaa511","article-title":"Otological aspects of NLRP3-related autoinflammatory disorder focusing on the responsiveness to anakinra","volume":"60","author":"Kim","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109287_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40463-018-0256-0","article-title":"Resolution of unilateral sensorineural hearing loss in a pediatric patient with a severe phenotype of Muckle-Wells syndrome treated with Anakinra: a case report and review of the literature","volume":"47","author":"Marchica","year":"2018","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.clim.2023.109287_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.890256","article-title":"Auditory phenotype and histopathologic findings of a mutant Nlrp3 expression mouse model","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clim.2023.109287_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104184","article-title":"Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model","volume":"82","author":"Ma","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clim.2023.109287_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21053\/ceo.2021.00920","article-title":"Cytokines and inflammation in Meniere disease","volume":"15","author":"Frejo","year":"2022","journal-title":"Clin. Exp. Otorhinolaryngol."},{"key":"10.1016\/j.clim.2023.109287_bb0150","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14417.1","article-title":"Towards personalized medicine in Meniere\u2019s disease","volume":"7","author":"Lopez-Escamez","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.clim.2023.109287_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026759","article-title":"High prevalence of systemic autoimmune diseases in patients with Meniere's disease","volume":"6","author":"Gazquez","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109287_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00405-009-1122-5","article-title":"Vertigo and autoimmunity","volume":"267","author":"Bovo","year":"2010","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.clim.2023.109287_bb0165","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1038\/s41598-018-23911-4","article-title":"Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease","volume":"8","author":"Frejo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109287_bb0170","doi-asserted-by":"crossref","first-page":"5072582","DOI":"10.1155\/2018\/5072582","article-title":"Update on vertigo in autoimmune disorders, from diagnosis to treatment","volume":"2018","author":"Girasoli","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clim.2023.109287_bb0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.semarthrit.2004.07.001","article-title":"Immune-mediated inner ear disease: 10-year experience","volume":"34","author":"Broughton","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109287_bb0180","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4049\/jimmunol.1002275","article-title":"IL-1beta is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease","volume":"186","author":"Pathak","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2023.109287_bb0185","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1172\/JCI76503","article-title":"Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease","volume":"124","author":"Vambutas","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109287_bb0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130845","article-title":"Autoimmune inner ear disease patient-associated 28-kDa proinflammatory IL-1beta fragment results from caspase-7-mediated cleavage in vitro","volume":"5","author":"Pathak","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2023.109287_bb0195","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.anorl.2017.12.011","article-title":"International consensus (ICON) on treatment of sudden sensorineural hearing loss","volume":"135","author":"Marx","year":"2018","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"10.1016\/j.clim.2023.109287_bb0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/lary.26133","article-title":"Quality of life and hearing eight years after sudden sensorineural hearing loss","volume":"127","author":"Harkonen","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clim.2023.109287_bb0205","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.clim.2023.109287_bb0210","doi-asserted-by":"crossref","DOI":"10.1111\/coa.14036","article-title":"Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis","author":"Chaushu","year":"2023","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.clim.2023.109287_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-249191","article-title":"Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor","volume":"15","author":"Gunderman","year":"2022","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clim.2023.109287_bb0220","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2169\/internalmedicine.7674-21","article-title":"Atypical Cogan\u2019s syndrome mimicking Giant cell arteritis successfully treated with early administration of Tocilizumab","volume":"61","author":"Hara","year":"2022","journal-title":"Intern. Med."},{"key":"10.1016\/j.clim.2023.109287_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233330","article-title":"Macrophage activation syndrome as an initial presentation of systemic lupus erythematosus with sensorineural hearing loss in a young male patient","volume":"13","author":"Tan","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clim.2023.109287_bb0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-022-04987-3","article-title":"The protective effects of systemic dexamethasone on sensory epithelial damage and hearing loss in targeted Cx26-null mice","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2023.109287_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAO.0000000000000254","article-title":"Metabolomic and network analysis of pharmacotherapies for sensorineural hearing loss","volume":"35","author":"Muurling","year":"2014","journal-title":"Otol Neurotol."},{"key":"10.1016\/j.clim.2023.109287_bb0240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.smim.2018.09.001","article-title":"NLRP3 inflammasome activation in inflammaging","volume":"40","author":"Latz","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2023.109287_bb0245","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","article-title":"Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging","volume":"18","author":"Youm","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.clim.2023.109287_bb0250","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033217","article-title":"Age-related hearing loss","volume":"9","author":"Bowl","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.clim.2023.109287_bb0255","article-title":"Aging brain and hearing: a mini-review","volume":"13","author":"Uchida","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.clim.2023.109287_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.814528","article-title":"Age-related hearing loss: sensory and neural etiology and their interdependence","volume":"14","author":"Elliott","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.clim.2023.109287_bb0265","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ageing\/afr140","article-title":"Markers of inflammatory status are associated with hearing threshold in older people: findings from the Hertfordshire Ageing Study","volume":"41","author":"Verschuur","year":"2012","journal-title":"Age Ageing"},{"key":"10.1016\/j.clim.2023.109287_bb0270","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/gerona\/glt075","article-title":"Long-term assessment of systemic inflammation and the cumulative incidence of age-related hearing impairment in the epidemiology of hearing loss study","volume":"69","author":"Nash","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.clim.2023.109287_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258977","article-title":"Upregulation of a nuclear factor-kappa B-interacting immune gene network in mice cochleae with age-related hearing loss","volume":"16","author":"Uraguchi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109287_bb0280","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.4103\/1673-5374.339499","article-title":"Involvement of NLRP3-inflammasome pathway in noise-induced hearing loss","volume":"17","author":"Sai","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.clim.2023.109287_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107576","article-title":"Oridonin ameliorates noise-induced hearing loss by blocking NLRP3 - NEK7 mediated inflammasome activation","volume":"95","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2023.109287_bb0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molimm.2022.06.006","article-title":"Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3\/caspase-1\/gasdermin D-induced inflammasome activation and hair cell pyroptosis","volume":"149","author":"Wu","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2023.109287_bb0295","article-title":"Cochlear marginal cell pyroptosis is induced by cisplatin via NLRP3 inflammasome activation","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109287_bb0300","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1017\/S0022215110000460","article-title":"Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2","volume":"124","author":"Neary","year":"2010","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.clim.2023.109287_bb0305","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/coa.12882","article-title":"Hearing optimisation in neurofibromatosis type 2: a systematic review","volume":"42","author":"Lloyd","year":"2017","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.clim.2023.109287_bb0310","first-page":"312","article-title":"Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic neuromas)","volume":"17","author":"Nadol","year":"1996","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.clim.2023.109287_bb0315","first-page":"465","article-title":"Clinical correlates of acoustic neuroma volume","volume":"14","author":"Arriaga","year":"1993","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.clim.2023.109287_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000096152","article-title":"Hearing in patients with intracanalicular vestibular schwannomas","volume":"12","author":"Caye-Thomasen","year":"2007","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.clim.2023.109287_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.836504","article-title":"Sporadic vestibular schwannoma size and location do not correlate with the severity of hearing loss at initial presentation","volume":"12","author":"Brown","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2023.109287_bb0330","article-title":"The inflammatory microenvironment in vestibular schwannoma","volume":"2","author":"Hannan","year":"2020","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.clim.2023.109287_bb0335","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X211059111","article-title":"Tumor-associated macrophages in vestibular schwannoma and relationship to hearing","volume":"5","author":"Nisenbaum","year":"2021","journal-title":"OTO Open"},{"key":"10.1016\/j.clim.2023.109287_bb0340","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MAO.0b013e31828048ec","article-title":"Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size","volume":"34","author":"Dilwali","year":"2013","journal-title":"Otol Neurotol."},{"key":"10.1016\/j.clim.2023.109287_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd4816","article-title":"Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models","volume":"13","author":"Wu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2023.109287_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2019.07.007","article-title":"NLRP3 inflammasome activation in human vestibular schwannoma: implications for tumor-induced hearing loss","volume":"381","author":"Sagers","year":"2019","journal-title":"Hear. Res."},{"key":"10.1016\/j.clim.2023.109287_bb0355","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/00016489.2022.2076905","article-title":"Efficacy of steroid treatment for sudden sensorineural hearing loss in patients with vestibular schwannoma","volume":"142","author":"Lee","year":"2022","journal-title":"Acta Otolaryngol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:08:04Z","timestamp":1761494884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":71,"alternative-id":["S1521661623000669"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109287","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NLRP3 inflammasome as a target for sensorineural hearing loss","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109287"}}